Hacker News with Generative AI: Drug Development

Progress and prospects of mRNA-based drugs in pre-clinical/clinical applications (nature.com)
In the last decade, messenger ribonucleic acid (mRNA)-based drugs have gained great interest in both immunotherapy and non-immunogenic applications.
Drug Development Failure: how GLP-1 development was abandoned in 1990 (muse.jhu.edu)
What good are whizzy new drugs if the world can't afford them? (economist.com)
How A.I. Is Revolutionizing Drug Development (nytimes.com)
Cost of developing new drugs may be lower than industry claims: trial (theguardian.com)